Literature DB >> 2111649

Screening for thyroid disease.

M Helfand1, L M Crapo.   

Abstract

PURPOSE: To evaluate the usefulness of screening for thyroid dysfunction in various clinical settings.
DESIGN: Review and synthesis of the literature. MAIN
RESULTS: Screening in the community detects new overt thyrotoxicosis or hypothyroidism in approximately 0.5% of the general population. The yield is best among women over 40 years of age (1%) and is lowest among young men (0%). Case-finding (testing clinic patients who are seeing a physician for unrelated reasons) has a better yield and is less expensive than screening in the community. Patients hospitalized with acute illnesses do not benefit from routine thyroid function testing. However, patients who are admitted to specialized geriatric units because of general disability, failure to thrive, and other indications may benefit. In various studies, from 2% to 5% of patients admitted to geriatric units have treatable thyroid disease. The serum total thyroxine, free thyroxine index, free thyroxine, and sensitive thyrotropin assay are all effective as initial tests for screening. The sensitive thyrotropin assay is less cost-effective than the other choices. RECOMMENDATIONS: Case-finding in some women over 40 years of age can be useful. Patients admitted to specialized geriatric units may also benefit from routine testing. Thyroid function tests are not indicated for community screening programs or for patients hospitalized with acute medical or psychiatric illnesses.

Entities:  

Mesh:

Year:  1990        PMID: 2111649     DOI: 10.7326/0003-4819-112-11-840

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  17 in total

1.  Prevalence of subclinical hypothyroidism in a population living in the Milan metropolitan area.

Authors:  G Rivolta; R Cerutti; R Colombo; G Miano; P Dionisio; E Grossi
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Subclinical hypothyroidism revisited. When is not enough really not enough?

Authors:  D R Goldmann
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

3.  Normal thyroxine and elevated thyrotropin concentrations: evolving hypothyroidism or persistent euthyroidism with reset thyrostat.

Authors:  U M Kabadi; R Cech
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

4.  [Prevalence of thyroid gland dysfunctions in 50- to 80-year-old patients. An epidemiologic cross-sectional study in a southwestern community].

Authors:  T Seck; C Scheidt-Nave; R Ziegler; J Pfeilschifter
Journal:  Med Klin (Munich)       Date:  1997-11-15

5.  Do traditional symptoms of hypothyroidism correlate with biochemical disease?

Authors:  G J Canaris; J F Steiner; E C Ridgway
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

6.  Cost effectiveness of screening for subclinical hypothyroidism in the elderly. A decision-analytical model.

Authors:  M Bona; F Santini; G Rivolta; E Grossi; R Grilli
Journal:  Pharmacoeconomics       Date:  1998-08       Impact factor: 4.981

7.  Unmasking Hyperthyroidism in the Elderly: How to distinguish hyperthyroidism from conditions that mimic the symptoms.

Authors:  M Gordon; Y Isenberg; J Bain
Journal:  Can Fam Physician       Date:  1992-10       Impact factor: 3.275

Review 8.  Clinical use of sensitive assays for thyroid-stimulating hormone.

Authors:  P A Masters; R J Simons
Journal:  J Gen Intern Med       Date:  1996-02       Impact factor: 5.128

9.  Evaluation of hormonal testing in the screening for in vitro fertilization (IVF) of women with tubal factor infertility.

Authors:  M R Laufer; A E Floor; K E Parsons; K M Kuntz; R L Barbieri; A J Friedman
Journal:  J Assist Reprod Genet       Date:  1995-02       Impact factor: 3.412

10.  Prevalence of subclinical hypothyroidism in patients with chronic kidney disease.

Authors:  Michel Chonchol; Giuseppe Lippi; Gianluca Salvagno; Giacomo Zoppini; Michele Muggeo; Giovanni Targher
Journal:  Clin J Am Soc Nephrol       Date:  2008-06-11       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.